Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)

Donna M. Evon, Abdus S. Wahed, Geoffrey Johnson, Mandana Khalili, Mauricio Lisker-Melman, Robert J. Fontana, Souvik Sarkar, Bryce B. Reeve, Jay H. Hoofnagle

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Fatigue is a common symptom of liver disease but not well characterized in patients with chronic hepatitis B virus (HBV). Aims: We assessed the rate of fatigue using a validated instrument in patients with HBV and identified demographic, virologic, and clinical features associated with fatigue in a cross-sectional cohort study from the Hepatitis B Research Network. Methods: Participants were English- and Spanish-speaking adults with chronic HBV who were not pregnant nor on treatment. Fatigue was measured using the PROMIS® Fatigue 7-item Short Form. Results: The sample included 948 adults: median age 42; 51 % female; 71 % Asian; 74 % college educated; 77 % employed; 41 % inactive HBV carriers; 36 % with active chronic disease; and 2 % with advanced fibrosis, defined as AST–platelet ratio index (APRI) > 1.50. Patients with chronic HBV had a mean fatigue T-score of 46.8 ± SD = 7.9, compared to a mean fatigue T-score of 50.0 ± 10 in the US general population (p < .0001). In univariate analyses, greater fatigue was associated with demographic and clinical features such as female sex, lower income, more comorbidities, higher APRI score, and poorer mental health (p < 0.05). In multivariate analysis, female sex (p < .001), poorer mental health (p < .001), APRI score (p = .005), and history of diabetes (p = .039) were the strongest independent predictors. Conclusions: The frequency of fatigue in this large cohort of North American chronic HBV patients may be equal to or lower than that reported in the US general population. Patients with advanced fibrosis, more comorbidities, and poorer mental health report worse fatigue.

Original languageEnglish (US)
Pages (from-to)1186-1196
Number of pages11
JournalDigestive Diseases and Sciences
Volume61
Issue number4
DOIs
StatePublished - Apr 1 2016

Fingerprint

Chronic Hepatitis B
North America
Hepatitis B
Fatigue
Hepatitis B virus
Research
Mental Health
Comorbidity
Fibrosis
Demography
Population
Liver Diseases
Chronic Disease
Cohort Studies
Multivariate Analysis
Cross-Sectional Studies

Keywords

  • Liver
  • Mental health
  • Patient-reported outcomes
  • PROMIS
  • Symptoms

ASJC Scopus subject areas

  • Physiology
  • Gastroenterology

Cite this

Evon, D. M., Wahed, A. S., Johnson, G., Khalili, M., Lisker-Melman, M., Fontana, R. J., ... Hoofnagle, J. H. (2016). Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Digestive Diseases and Sciences, 61(4), 1186-1196. https://doi.org/10.1007/s10620-015-4006-0

Fatigue in Patients with Chronic Hepatitis B Living in North America : Results from the Hepatitis B Research Network (HBRN). / Evon, Donna M.; Wahed, Abdus S.; Johnson, Geoffrey; Khalili, Mandana; Lisker-Melman, Mauricio; Fontana, Robert J.; Sarkar, Souvik; Reeve, Bryce B.; Hoofnagle, Jay H.

In: Digestive Diseases and Sciences, Vol. 61, No. 4, 01.04.2016, p. 1186-1196.

Research output: Contribution to journalArticle

Evon, DM, Wahed, AS, Johnson, G, Khalili, M, Lisker-Melman, M, Fontana, RJ, Sarkar, S, Reeve, BB & Hoofnagle, JH 2016, 'Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)', Digestive Diseases and Sciences, vol. 61, no. 4, pp. 1186-1196. https://doi.org/10.1007/s10620-015-4006-0
Evon, Donna M. ; Wahed, Abdus S. ; Johnson, Geoffrey ; Khalili, Mandana ; Lisker-Melman, Mauricio ; Fontana, Robert J. ; Sarkar, Souvik ; Reeve, Bryce B. ; Hoofnagle, Jay H. / Fatigue in Patients with Chronic Hepatitis B Living in North America : Results from the Hepatitis B Research Network (HBRN). In: Digestive Diseases and Sciences. 2016 ; Vol. 61, No. 4. pp. 1186-1196.
@article{03632391548941e4bc934a6d7e24f759,
title = "Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)",
abstract = "Background: Fatigue is a common symptom of liver disease but not well characterized in patients with chronic hepatitis B virus (HBV). Aims: We assessed the rate of fatigue using a validated instrument in patients with HBV and identified demographic, virologic, and clinical features associated with fatigue in a cross-sectional cohort study from the Hepatitis B Research Network. Methods: Participants were English- and Spanish-speaking adults with chronic HBV who were not pregnant nor on treatment. Fatigue was measured using the PROMIS{\circledR} Fatigue 7-item Short Form. Results: The sample included 948 adults: median age 42; 51 {\%} female; 71 {\%} Asian; 74 {\%} college educated; 77 {\%} employed; 41 {\%} inactive HBV carriers; 36 {\%} with active chronic disease; and 2 {\%} with advanced fibrosis, defined as AST–platelet ratio index (APRI) > 1.50. Patients with chronic HBV had a mean fatigue T-score of 46.8 ± SD = 7.9, compared to a mean fatigue T-score of 50.0 ± 10 in the US general population (p < .0001). In univariate analyses, greater fatigue was associated with demographic and clinical features such as female sex, lower income, more comorbidities, higher APRI score, and poorer mental health (p < 0.05). In multivariate analysis, female sex (p < .001), poorer mental health (p < .001), APRI score (p = .005), and history of diabetes (p = .039) were the strongest independent predictors. Conclusions: The frequency of fatigue in this large cohort of North American chronic HBV patients may be equal to or lower than that reported in the US general population. Patients with advanced fibrosis, more comorbidities, and poorer mental health report worse fatigue.",
keywords = "Liver, Mental health, Patient-reported outcomes, PROMIS, Symptoms",
author = "Evon, {Donna M.} and Wahed, {Abdus S.} and Geoffrey Johnson and Mandana Khalili and Mauricio Lisker-Melman and Fontana, {Robert J.} and Souvik Sarkar and Reeve, {Bryce B.} and Hoofnagle, {Jay H.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s10620-015-4006-0",
language = "English (US)",
volume = "61",
pages = "1186--1196",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - Fatigue in Patients with Chronic Hepatitis B Living in North America

T2 - Results from the Hepatitis B Research Network (HBRN)

AU - Evon, Donna M.

AU - Wahed, Abdus S.

AU - Johnson, Geoffrey

AU - Khalili, Mandana

AU - Lisker-Melman, Mauricio

AU - Fontana, Robert J.

AU - Sarkar, Souvik

AU - Reeve, Bryce B.

AU - Hoofnagle, Jay H.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background: Fatigue is a common symptom of liver disease but not well characterized in patients with chronic hepatitis B virus (HBV). Aims: We assessed the rate of fatigue using a validated instrument in patients with HBV and identified demographic, virologic, and clinical features associated with fatigue in a cross-sectional cohort study from the Hepatitis B Research Network. Methods: Participants were English- and Spanish-speaking adults with chronic HBV who were not pregnant nor on treatment. Fatigue was measured using the PROMIS® Fatigue 7-item Short Form. Results: The sample included 948 adults: median age 42; 51 % female; 71 % Asian; 74 % college educated; 77 % employed; 41 % inactive HBV carriers; 36 % with active chronic disease; and 2 % with advanced fibrosis, defined as AST–platelet ratio index (APRI) > 1.50. Patients with chronic HBV had a mean fatigue T-score of 46.8 ± SD = 7.9, compared to a mean fatigue T-score of 50.0 ± 10 in the US general population (p < .0001). In univariate analyses, greater fatigue was associated with demographic and clinical features such as female sex, lower income, more comorbidities, higher APRI score, and poorer mental health (p < 0.05). In multivariate analysis, female sex (p < .001), poorer mental health (p < .001), APRI score (p = .005), and history of diabetes (p = .039) were the strongest independent predictors. Conclusions: The frequency of fatigue in this large cohort of North American chronic HBV patients may be equal to or lower than that reported in the US general population. Patients with advanced fibrosis, more comorbidities, and poorer mental health report worse fatigue.

AB - Background: Fatigue is a common symptom of liver disease but not well characterized in patients with chronic hepatitis B virus (HBV). Aims: We assessed the rate of fatigue using a validated instrument in patients with HBV and identified demographic, virologic, and clinical features associated with fatigue in a cross-sectional cohort study from the Hepatitis B Research Network. Methods: Participants were English- and Spanish-speaking adults with chronic HBV who were not pregnant nor on treatment. Fatigue was measured using the PROMIS® Fatigue 7-item Short Form. Results: The sample included 948 adults: median age 42; 51 % female; 71 % Asian; 74 % college educated; 77 % employed; 41 % inactive HBV carriers; 36 % with active chronic disease; and 2 % with advanced fibrosis, defined as AST–platelet ratio index (APRI) > 1.50. Patients with chronic HBV had a mean fatigue T-score of 46.8 ± SD = 7.9, compared to a mean fatigue T-score of 50.0 ± 10 in the US general population (p < .0001). In univariate analyses, greater fatigue was associated with demographic and clinical features such as female sex, lower income, more comorbidities, higher APRI score, and poorer mental health (p < 0.05). In multivariate analysis, female sex (p < .001), poorer mental health (p < .001), APRI score (p = .005), and history of diabetes (p = .039) were the strongest independent predictors. Conclusions: The frequency of fatigue in this large cohort of North American chronic HBV patients may be equal to or lower than that reported in the US general population. Patients with advanced fibrosis, more comorbidities, and poorer mental health report worse fatigue.

KW - Liver

KW - Mental health

KW - Patient-reported outcomes

KW - PROMIS

KW - Symptoms

UR - http://www.scopus.com/inward/record.url?scp=84961119519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961119519&partnerID=8YFLogxK

U2 - 10.1007/s10620-015-4006-0

DO - 10.1007/s10620-015-4006-0

M3 - Article

C2 - 26831489

AN - SCOPUS:84961119519

VL - 61

SP - 1186

EP - 1196

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 4

ER -